Monographie - Amphotericin B cholesteryl sulfate complex

Viimeisin päivitys :
19/11/2024

Amphotericin B cholesteryl sulfate complex

Kemiallinen rakenne

Kauppanimi

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Amphotec

Iso-Britannia, Itävalta, Kreikka, Puola, Slovenia, Turkki, Yhdysvallat

Viitteet : Amphotericin B cholesteryl sulfate complex

	tyyppi	julkaisu
921	Lehti	Trissel LA, Gilbert DL, Martinez JF. Incompatibility and compatibility of amphotericin B cholesteryl sulfate complex with selected other drugs during simulated Y-site administration. Hosp Pharm 1998 ; 33: 284-292.
1407	Lehti	Xu QA, Trissel LA, Gilbert DL. Stability of amphotericin B cholesteryl sulfate complex after reconstitution and admixture. Hosp Pharm 1998 ; 33: 1203-1207.
1982	Lehti	Trissel LA, Ogundele AB. Compatibility of anidulafungin with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2005 ; 62: 834-837.
2262	Lehti	Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D. Compatibility of doripenem with other drugs during simulated Y-site administratioN Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
3578	Laboratorio	Cisplatin - Summary of Product Characteristics Accord Healthcare 2011
3644	Laboratorio	Calcium gluconate® - Summary of Product Characteristics Hameln Pharmaceuticals 2010

Mentions Légales